Bradley Nagel Sells 11,801 Shares of Electromed (NYSE:ELMD) Stock

Electromed, Inc. (NYSE:ELMD) CFO Bradley Nagel sold 11,801 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $36.35, for a total transaction of $428,966.35. Following the completion of the transaction, the chief financial officer directly owned 19,638 shares of the company’s stock, valued at approximately $713,841.30. This represents a 37.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Electromed Price Performance

ELMD stock opened at $36.29 on Wednesday. Electromed, Inc. has a one year low of $17.73 and a one year high of $40.00. The stock has a market cap of $300.48 million, a PE ratio of 48.39 and a beta of 0.53. The firm has a 50 day simple moving average of $30.02 and a two-hundred day simple moving average of $27.95.

Analyst Upgrades and Downgrades

ELMD has been the subject of a number of recent research reports. Zacks Research upgraded shares of Electromed from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. B. Riley Financial boosted their price objective on shares of Electromed from $38.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Finally, Roth Mkm restated a “buy” rating and issued a $38.00 price objective on shares of Electromed in a report on Wednesday, February 11th. One analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $37.50.

Institutional Investors Weigh In On Electromed

A number of hedge funds have recently made changes to their positions in the business. Bank of America Corp DE lifted its holdings in shares of Electromed by 49.3% in the 1st quarter. Bank of America Corp DE now owns 17,059 shares of the company’s stock worth $399,000 after acquiring an additional 5,634 shares during the last quarter. Lazard Asset Management LLC boosted its position in Electromed by 10.8% during the 1st quarter. Lazard Asset Management LLC now owns 95,213 shares of the company’s stock valued at $2,229,000 after buying an additional 9,269 shares during the period. Punch & Associates Investment Management Inc. boosted its position in Electromed by 20.1% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 224,520 shares of the company’s stock valued at $5,256,000 after buying an additional 37,500 shares during the period. Gabelli Funds LLC boosted its position in Electromed by 10.9% during the 1st quarter. Gabelli Funds LLC now owns 40,700 shares of the company’s stock valued at $953,000 after buying an additional 4,000 shares during the period. Finally, Aristides Capital LLC boosted its position in Electromed by 22.1% during the 1st quarter. Aristides Capital LLC now owns 33,332 shares of the company’s stock valued at $780,000 after buying an additional 6,030 shares during the period. 40.82% of the stock is currently owned by institutional investors.

About Electromed

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.